Breast Gene Discovery Could Transform Treatment

Thursday, 07 Feb 2013 02:12 PM

By Nick Tate

  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
Scientists have discovered a genetic defect implicated in the majority of breast cancers — a finding that may change the way the disease is diagnosed and treated.

In a new report in the journal Nature, University of Minnesota researchers said they have identified a human enzyme that causes DNA mutations seen in breast cancer patients. The identification of the enzyme — called APOBEC3B — could pave the way for the development of new screening tests, prevention approaches, and therapies for breast cancer.

"We strongly believe this discovery will change the way mutations in cancer are viewed,” said Reuben Harris, an associate professor of biochemistry, molecular biology, and biophysics who helped lead the research that led to the finding. “And, hopefully, it will allow cancer researchers to develop new treatments [and] approaches that can prevent these mutations before they become harmful."

Special: This Small Group of Doctors are Quietly Curing Cancer

The discovery by Harris and colleagues was an outgrowth of the team’s HIV research, which had found APOBEC3B and related enzymes can protect people from some infectious viruses. But in studying the enzyme, Harris and his team found DNA mutations cause APOBEC3B to be produced in great quantities in breast cancer patients’ cell lines and tumors.

As a result, the enzyme is a biological "double-edged sword" — offering protection from some viruses, such as HIV, but produces mutations that promote cancer, he said.

"DNA mutations are absolutely essential for cancer development," said Harris. "Our experiments showed the APOBEC3B enzyme causes mutations in the genome of breast cancer cells. From this, we were able to reasonably conclude that the APOBEC3B is a key influencer in breast cancer."

Harris said the findings suggest high APOBEC3B levels could be tracked to indicate the early presence of breast cancer through a simple blood test that could speed treatments.

The research may also pave the way for developing new drugs that block APOBEC3B from causing DNA mutations, “just as sunscreen prevents sun from causing mutations leading to melanoma,” he said.

“Ultimately, we hope our discovery leads to better therapeutic outcomes for patients," added Harris.

© 2014 NewsmaxHealth. All rights reserved.

  Comment  |
   Contact Us  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Retype Email:
Zip Code:
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Apple-Shaped Women Not At Greater Breast Cancer Risk: Study

Friday, 18 Apr 2014 16:04 PM

Body shape -- whether a woman is wide at the waistline -- is not in itself a risk factor for breast cancer, according to . . .

Prostate Cancer Patients Often Abandon 'Watchful Waiting'

Friday, 18 Apr 2014 12:04 PM

Doctors often recommend no treatment at all when a man is diagnosed with prostate cancer, opting instead to keep a close . . .

Fibroid Procedure Can Spread Cancer in Women, FDA Warns

Thursday, 17 Apr 2014 16:15 PM

The FDA is warning doctors to stop using a procedure performed on tens of thousands of American women each year during u . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved